Manchester, UK – RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems today announces the availability of the New 2010 Specification A3 SmaRTStore™whichoffers exceptional storage density and improved future proofing.

Well established in the marketplace as a leading, high quality automated storage and retrieval system for both compounds and biological samples, the new A3 SmaRTStore™ has been developed as a result of continued product improvement and now comes with a high specification modular cold room enclosure.

Key benefits of the new A3 specification include: easily extendable post-installation enabling your A3 SmaRTStore™ to grow in line with your sample collection, extremely maintenance friendly and, a unique floor design ensuring rapid on-site installation and minimal impact on facilities.

A new range of reliable and flexible refrigeration systems is also available, with both local and remote sited compressor options providing maximum flexibility for installation and facilities management. The class-leading storage density and RTS d-Sprint™ software for which A3 SmaRTStore™ is renowned, combined with the new refrigeration and cold room options mean that the new 2010 specification A3 SmaRTStore™ is the most flexible, reliable and space efficient automated sample management solution on the market today.

Both the standard A3 SmaRTStore™, and the new A3+, which offers an additional 50% storage capacity, ensure that samples are held in the best storage environment possible.

About RTS

RTS Life Science is a UK-based supplier of laboratory automation products and solutions for drug discovery, delivery and quality control applications within pharmaceutical, biotech, biobanking and academic institutes. RTS Life Science is owned by Robotic Technology Systems PLC, an AIM-listed company.